To the Editor: Gerntholtz et al.
1 report their series of kidney biopsies from Black African human immunodeficiency virus (HIV)-positive patients, adding to a growing literature suggesting HIV-associated nephropathy (HIVAN) to be less common than originally described. 2, 3 They found HIV immune complex kidney disease to be as common as HIVAN, and describe for the first time a 'ball-in-cup' appearance on silver-methenamine staining or electron microscopy caused by subepithelial deposits associated with basement membrane reaction, placing this lesion as an intermediate between classical post-infectious and membranous glomerulonephritis.
On review of 10 Black African HIV-positive patients biopsied in East London after July 2004, we found a similar prevalence of HIVAN (3/10) and immune complex-mediated glomerulonephritis with mesangial matrix increase and crescent formation (3/10). The 'ball-in-cup' lesion newly described as typical of HIV immune complex kidney disease was apparent in only one of the three such cases on re-examining The kidney biopsy experience of Cove-Smith et al. 1 in an East London setting with Black African human immunodeficiency virus (HIV)-positive patients is interesting in its parallels to ours. We feel that this emphasizes the fact that not all that is kidney disease in the context of HIV infection is classic HIV-associated nephropathy. There are many other forms of renal pathology which occur, emphasizing the need for renal biopsy to allow full clarification.
Although detailed histopathological clarification does not carry proven therapeutic implications at this stage, we are at present treating all those with HIV-associated nephropathy and HIV immune complex kidney disease with angiotensin-converting enzyme inhibitors and antiretroviral therapy, regardless of the CD4 count, as we feel that the virus is involved in the pathophysiology. This contrasts with our published experience, 2 when antiretroviral therapies were not used as they were not available to us. It is our emerging but distinct impression that our results are much improved, in agreement with Cove-Smith et al. 1 We would thus argue for these two nephropathies (HIV-associated nephropathy and HIV immune complex kidney disease) to be considered World Health Organization stage 4 HIV conditions, requiring antiretroviral therapy treatment in themselves, regardless of other clinical parameters.
